Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors after the Introduction of Biosimilar Infliximab in the U.S.

Kim SC, Sarpatwari A, Landon JE, Desai RJ.

Arthritis Rheumatol. 2020 Jan 13. doi: 10.1002/art.41201. [Epub ahead of print]

PMID:
31943866
2.

Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes.

Desai RJ, Wang SV, Vaduganathan M, Evers T, Schneeweiss S.

JAMA Netw Open. 2020 Jan 3;3(1):e1918962. doi: 10.1001/jamanetworkopen.2019.18962.

3.

Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States.

Desai RJ, Sarpatwari A, Gautam N, Lii J, Fischer MA, Gagne JJ.

JAMA. 2020 Jan 7;323(1):87-89. doi: 10.1001/jama.2019.17521. No abstract available.

PMID:
31910271
4.

Comparative Outcomes of Treatment Initiation With Brand vs. Generic Warfarin in Older Patients.

Desai RJ, Gopalakrishnan C, Dejene S, Sarpatwari AS, Levin R, Dutcher SK, Wang Z, Wittayanukorn S, Franklin JM, Gagne JJ.

Clin Pharmacol Ther. 2019 Dec 23. doi: 10.1002/cpt.1743. [Epub ahead of print]

PMID:
31872419
5.

Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study.

Kang EH, Jin Y, Desai RJ, Liu J, Sparks JA, Kim SC.

Semin Arthritis Rheum. 2019 Nov 15. pii: S0049-0172(19)30691-2. doi: 10.1016/j.semarthrit.2019.11.010. [Epub ahead of print]

PMID:
31813561
6.

Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners.

Desai RJ, Franklin JM.

BMJ. 2019 Oct 23;367:l5657. doi: 10.1136/bmj.l5657. No abstract available.

PMID:
31645336
7.

Use of Time-Dependent Propensity Scores to Adjust Hazard Ratio Estimates in Cohort Studies with Differential Depletion of Susceptibles.

Wyss R, Gagne JJ, Zhao Y, Zhou EH, Major JM, Wang SV, Desai RJ, Franklin JM, Schneeweiss S, Toh S, Johnson M, Fireman B.

Epidemiology. 2020 Jan;31(1):82-89. doi: 10.1097/EDE.0000000000001107.

PMID:
31569120
8.

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications.

Desai RJ, Good MM, San-Juan-Rodriguez A, Henriksen A, Cunningham F, Hernandez I, Good CB.

JAMA Netw Open. 2019 Sep 4;2(9):e1910626. doi: 10.1001/jamanetworkopen.2019.10626.

9.

Risk of serious infection among initiators of TNF inhibitors plus methotrexate versus triple therapy for rheumatoid arthritis: a cohort study.

Kang EH, Jin Y, Tong AY, Desai RJ, Kim SC.

Arthritis Care Res (Hoboken). 2019 Aug 3. doi: 10.1002/acr.24038. [Epub ahead of print]

PMID:
31376333
10.

Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement.

Kim SC, Jin Y, Lee YC, Lii J, Franklin PD, Solomon DH, Franklin JM, Katz JN, Desai RJ.

JAMA Netw Open. 2019 Jul 3;2(7):e198061. doi: 10.1001/jamanetworkopen.2019.8061.

11.

Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.

Desai RJ, Kim SC, Curtis JR, Bosco JLF, Eichelberger B, Barr CE, Lockhart CM, Bradbury BD, Clewell J, Cohen HP, Gagne JJ; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Switching Workgroup.

Pharmacoepidemiol Drug Saf. 2019 Jul 12. doi: 10.1002/pds.4809. [Epub ahead of print] Review.

PMID:
31298463
12.

Unraveling the Role of Nonsteroidal Antiinflammatory Drugs in the Link Between Osteoarthritis and Cardiovascular Disease via Causal Mediation Analysis: A Guide to Interpretation.

Yoshida K, Desai RJ.

Arthritis Rheumatol. 2019 Nov;71(11):1776-1779. doi: 10.1002/art.41028. Epub 2019 Sep 5. No abstract available.

PMID:
31259487
13.

Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes.

Cohen JM, Huybrechts KF, Patorno E, Desai RJ, Mogun H, Bateman BT, Hernández-Díaz S.

J Clin Psychiatry. 2019 Jun 18;80(4). pii: 18m12572. doi: 10.4088/JCP.18m12572.

PMID:
31237992
14.

Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study.

Chen SK, Feldman CH, Brill G, Lee YC, Desai RJ, Kim SC.

BMJ Open. 2019 Jun 19;9(6):e027495. doi: 10.1136/bmjopen-2018-027495.

15.

Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.

Spoendlin J, Paik JM, Tsacogianis T, Kim SC, Schneeweiss S, Desai RJ.

JAMA Intern Med. 2019 Jun 1;179(6):741-749. doi: 10.1001/jamainternmed.2019.0045.

PMID:
31058913
16.

Evaluating the use of bootstrapping in cohort studies conducted with 1:1 propensity score matching-A plasmode simulation study.

Desai RJ, Wyss R, Abdia Y, Toh S, Johnson M, Lee H, Karami S, Major JM, Nguyen M, Wang SV, Franklin JM, Gagne JJ.

Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):879-886. doi: 10.1002/pds.4784. Epub 2019 Apr 24.

PMID:
31020732
17.

Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study.

Kim SC, Pawar A, Desai RJ, Solomon DH, Gale S, Bao M, Sarsour K, Schneeweiss S.

Semin Arthritis Rheum. 2019 Oct;49(2):222-228. doi: 10.1016/j.semarthrit.2019.03.002. Epub 2019 Mar 9.

PMID:
30967248
18.

Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis.

Lee MP, Desai RJ, Jin Y, Brill G, Ogdie A, Kim SC.

JAMA Dermatol. 2019 Jun 1;155(6):700-707. doi: 10.1001/jamadermatol.2019.0001.

19.

Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.

Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ.

PLoS Med. 2019 Mar 13;16(3):e1002763. doi: 10.1371/journal.pmed.1002763. eCollection 2019 Mar.

20.

Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study.

Desai RJ, Jin Y, Franklin PD, Lee YC, Bateman BT, Lii J, Solomon DH, Katz JN, Kim SC.

Arthritis Rheumatol. 2019 May;71(5):712-721. doi: 10.1002/art.40834. Epub 2019 Apr 2.

PMID:
30688044
21.

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.

Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC.

Ann Rheum Dis. 2019 Apr;78(4):456-464. doi: 10.1136/annrheumdis-2018-214367. Epub 2019 Jan 24.

PMID:
30679153
22.

Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use.

Gopalakrishnan C, Gagne JJ, Sarpatwari A, Dejene SZ, Dutcher SK, Levin R, Franklin JM, Schneeweiss S, Desai RJ.

Clin Pharmacol Ther. 2019 Jun;105(6):1513-1521. doi: 10.1002/cpt.1348. Epub 2019 Feb 25.

PMID:
30659590
23.

Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.

Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM.

JAMA Netw Open. 2018 Jul 6;1(3):e180826. doi: 10.1001/jamanetworkopen.2018.0826.

24.

Role of Authorized Generics in Postapproval Surveillance of Generic Drug Products.

Gagne JJ, Sarpatwari A, Desai RJ.

Clin Pharmacol Ther. 2019 Feb;105(2):313-315. doi: 10.1002/cpt.1283. Epub 2018 Dec 28. No abstract available.

PMID:
30593655
25.

Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis.

Desai RJ, Mahesri M, Gagne JJ, Hurley E, Tong A, Chitnis T, Minden S, Spettell CM, Matlin OS, Shrank WH, Choudhry NK.

J Manag Care Spec Pharm. 2019 Jan;25(1):113-121. doi: 10.18553/jmcp.2019.25.1.113.

26.

Development and Preliminary Validation of a Medicare Claims-Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure.

Desai RJ, Lin KJ, Patorno E, Barberio J, Lee M, Levin R, Evers T, Wang SV, Schneeweiss S.

Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004700. doi: 10.1161/CIRCOUTCOMES.118.004700.

PMID:
30562067
27.

Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.

Huybrechts KF, Hernández-Díaz S, Straub L, Gray KJ, Zhu Y, Patorno E, Desai RJ, Mogun H, Bateman BT.

JAMA. 2018 Dec 18;320(23):2429-2437. doi: 10.1001/jama.2018.18307.

28.

Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study.

Desai RJ, Pawar A, Weinblatt ME, Kim SC.

Arthritis Rheumatol. 2019 Jun;71(6):892-900. doi: 10.1002/art.40798. Epub 2019 Apr 29.

PMID:
30552833
29.

Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome.

Spoendlin J, Gagne JJ, Lewey JJ, Patorno E, Schneeweiss S, Desai RJ.

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1361-1370. doi: 10.1002/pds.4668. Epub 2018 Oct 31.

PMID:
30379372
30.

Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting System.

Rogers JR, Sarpatwari A, Desai RJ, Bohn JM, Khan NF, Kesselheim AS, Fischer MA, Gagne JJ, Connolly JG.

Drug Saf. 2019 Jan;42(1):85-93. doi: 10.1007/s40264-018-0703-x.

PMID:
30066315
31.

Network-based approach to prediction and population-based validation of in silico drug repurposing.

Cheng F, Desai RJ, Handy DE, Wang R, Schneeweiss S, Barabási AL, Loscalzo J.

Nat Commun. 2018 Jul 12;9(1):2691. doi: 10.1038/s41467-018-05116-5.

32.

Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study.

Panchaud A, Cohen JM, Patorno E, Huybrechts KF, Desai RJ, Gray KJ, Mogun H, Hernandez-Diaz S, Bateman BT.

Neurology. 2018 Aug 7;91(6):e533-e542. doi: 10.1212/WNL.0000000000005944. Epub 2018 Jul 6.

33.

Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes of Interest: An Empirical Evaluation.

Desai RJ, Wyss R, Jin Y, Bohn J, Toh S, Cosgrove A, Kennedy A, Kim J, Kim C, Ouellet-Hellstrom R, Karami S, Major JM, Niman A, Wang SV, Gagne JJ.

Am J Epidemiol. 2018 Nov 1;187(11):2439-2448. doi: 10.1093/aje/kwy130.

PMID:
29947726
34.

Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.

Zhang M, Solomon DH, Desai RJ, Kang EH, Liu J, Neogi T, Kim SC.

Circulation. 2018 Sep 11;138(11):1116-1126. doi: 10.1161/CIRCULATIONAHA.118.033992.

35.

Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis.

Spoendlin J, Schneeweiss S, Tsacogianis T, Paik JM, Fischer MA, Kim SC, Desai RJ.

Am J Kidney Dis. 2018 Aug;72(2):178-187. doi: 10.1053/j.ajkd.2018.03.027. Epub 2018 Jun 8.

PMID:
29891194
36.

Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease.

Jin Y, Kang EH, Brill G, Desai RJ, Kim SC.

J Rheumatol. 2018 Aug;45(9):1240-1248. doi: 10.3899/jrheum.170926. Epub 2018 May 15.

PMID:
29764964
37.

Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.

Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, Glynn RJ, Cohen LS, Mogun H, Huybrechts KF.

Am J Psychiatry. 2018 Jun 1;175(6):564-574. doi: 10.1176/appi.ajp.2018.17040393. Epub 2018 May 7.

38.

Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms.

Rough K, Huybrechts KF, Hernandez-Diaz S, Desai RJ, Patorno E, Bateman BT.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):62-69. doi: 10.1002/pds.4443. Epub 2018 Apr 24.

39.

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.

Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly J, Fischer MA, Kesselheim AS, Gagne JJ.

BMJ. 2018 Apr 3;361:k1180. doi: 10.1136/bmj.k1180.

40.

Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.

Kim SC, Neogi T, Kang EH, Liu J, Desai RJ, Zhang M, Solomon DH.

J Am Coll Cardiol. 2018 Mar 6;71(9):994-1004. doi: 10.1016/j.jacc.2017.12.052.

41.

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.

Desai RJ, Franklin JM, Spoendlin-Allen J, Solomon DH, Danaei G, Kim SC.

PLoS One. 2018 Feb 28;13(2):e0193622. doi: 10.1371/journal.pone.0193622. eCollection 2018.

42.

Characteristics of early acute respiratory distress syndrome in newly diagnosed acute myeloid leukemia.

Van de Louw A, Desai RJ, Zhu J, Claxton DF.

Leuk Lymphoma. 2018 Oct;59(10):2369-2376. doi: 10.1080/10428194.2018.1435874. Epub 2018 Feb 12.

PMID:
29431568
43.

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study.

Kang EH, Jin Y, Brill G, Lewey J, Patorno E, Desai RJ, Kim SC.

J Am Heart Assoc. 2018 Jan 24;7(3). pii: e007393. doi: 10.1161/JAHA.117.007393.

44.

Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015.

Bermas BL, Kim SC, Huybrechts K, Mogun H, Hernandez-Diaz S, Bateman BT, Desai RJ.

Lupus. 2018 Jan 1:961203317749046. doi: 10.1177/0961203317749046. [Epub ahead of print]

PMID:
29301469
45.

Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study.

Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Pennell PB, Bateman BT, Patorno E.

Neurology. 2018 Jan 23;90(4):e342-e351. doi: 10.1212/WNL.0000000000004857. Epub 2017 Dec 27.

46.
47.

Alendronate and Hip Fracture in Patients Using Glucocorticoids.

Desai RJ, Franklin JM, Kim SC.

JAMA. 2017 Nov 7;318(17):1711-1712. doi: 10.1001/jama.2017.14291. No abstract available.

PMID:
29114826
48.

Placental Complications Associated With Psychostimulant Use in Pregnancy.

Cohen JM, Hernández-Díaz S, Bateman BT, Park Y, Desai RJ, Gray KJ, Patorno E, Mogun H, Huybrechts KF.

Obstet Gynecol. 2017 Dec;130(6):1192-1201. doi: 10.1097/AOG.0000000000002362.

49.

Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts.

Franklin JM, Donneyong MM, Desai RJ, Markson L, Girman CJ, McKay C, Patel MD, Mavros P, Schneeweiss S.

J Comp Eff Res. 2017 Oct;6(7):613-625. doi: 10.2217/cer-2016-0095. Epub 2017 Oct 17.

PMID:
29039693
50.

Patterns of opioid initiation at first visits for pain in United States primary care settings.

Mundkur ML, Rough K, Huybrechts KF, Levin R, Gagne JJ, Desai RJ, Patorno E, Choudhry NK, Bateman BT.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):495-503. doi: 10.1002/pds.4322. Epub 2017 Oct 2.

Supplemental Content

Loading ...
Support Center